Richard NARJOZ

En résumé

Entreprises

• M.S.D. Belgium & Luxembourg - Hospital Product Specialist Immunology

  2016 - maintenant Development of our Immunology business

• Post Reorganization - Enhance my Skills

  2015 - 2016 Following the redevelopment after the merger between the 2 oncology part of Novartis and GSK, I had the opportunity to enhanced my skills.
  I kept and develop my working pharma network and also continue to be informed of the new scientific developments.
  

• Novartis - Hospital Product Specialist Oncology

  RUEIL MALMAISON 2006 - 2015 Renal Cell Carcinoma and Breast Cancer :
  - Everolimus (Afinitor ®) : mTOR inhibitor in advanced Breast Cancer and Renal Cell Carcinoma.
  - training programs for oncologists in CHU of Liège and Institut Bordet Bruxelles
  
  Gastro Enterology, Surgery and Endocrinology :
  -​Octreotide (Sandostatin®LAR®) an Octapeptide Somatostatin analog used for the treatment of Acromegaly and treatment of patients with symptoms associated with functional gastro-entero-pancreatic endocrine tumours to Gastroenterologists, Oncologists,Endocrinologists and Digestive surgeons.
  - Launch new diluent of Octreotide
  (Sandostatin®LAR®), 1 Year before Belgium, allowing me to become the leader of the market.
  
  Breast Cancer and Bone Metastasis : Specialist in my area for Breast Cancer.
  - Promotion of Letrozole (Femara ®) Aromatase inhibitor in Metastatic Breast cancer.
  - Launch of Letrozole (Femara ®) Aromatase inhibitor in Adjuvant Breast Cancer HR+

• Novartis - Project Associate Oncology

  RUEIL MALMAISON 2006 - 2006 Explore and find new targets (Gastroenterologists, Geriatricians, Surgeons, Internists) for the digestive oncology market and ensure sales development within the Business Unit Oncology . I directly reported to the Marketing/Sales director.
  
  

• GlaxoSmithKline - Hospital Product Specialist C.N.S. & Uro

  Marly-le-Roi 2002 - 2006 In charge of sales within the Neurology/Urology franchise in the Southeast France to the neurologists (Greatest center against epilepsy) and urologists. Lamotrigine (Lamictal®) in my area was the first market share France.
  In addition to ensuring the sales targets are met, I was involved as lead in the development of new projects with the neurology center of C.H.U Grenoble :
  - Movement disorders group for Grenoble area.
  - Regional interface in epilepsy and parkinson with the sales and marketing departments.
  

• GlaxoSmithKline - Medical Representative Gen Med/SP

  Marly-le-Roi 1994 - 2002 Development of sales and lauches in different sectors with practitioners and specialists in the following therapeutic areas: Anaesthesia,Cardiology,Dermatology, Gastroenterology, Neurology, Ophtalmology,Psychiatry,Virology.
  
  

Formations

• Université Jean Monnet , Faculté De Médecine Jacques Lisfranc

  Saint Etienne 1991 - 1993 DUDIM

• Lycée Tezenas Du Montcel

  St Etienne 1988 - 1991 Bac G3

• Lycée Notre Dame De Valbenoite Le Rond Point

  St Etienne 1983 - 1988